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ABSTRACT
Objective: Rauvolfia tetraphylla is a plant potentially applicable in Ayurvedic and Unani System of Medicine for the treatment of various diseases. 
However, the anticonvulsant activity of this plant has not been reported and studied. Therefore, the ethanolic extract of leaf from the plant R. tetraphylla 
is used to evaluate anticonvulsant activity.
Methods: Anticonvulsant activity was screened using maximal electroshock seizure (MES) model and pentylenetetrazole (PTZ)-induced seizure model 
in Swiss albino mice. The ethanolic extract was also evaluated for rutin and gallic acid content by high-performance thin-layer chromatography studies.
Results: Rutin and gallic acid contents were found as 15.60% and 7.81%, respectively. Ethanolic leaf extract (100–800 mg/kg) significantly reduced 
the duration of seizures which was induced by MES. The same doses also protected animals from PTZ-induced tonic seizures.
Conclusion: The study demonstrates that R. tetraphylla plant leaves have significant anticonvulsant activity.
Keywords: Anticonvulsant, High-performance thin-layer chromatography, Rauvolfia tetraphylla.
INTRODUCTION
It is now highlighted from literature work that the interest of human 
is continuously increased for the use of natural drugs/phytochemicals 
obtained from different plant sources for the treatment of various acute 
and chronic diseases because of their lesser side effects along with various 
neurological disorders. Epilepsy is a neurological disorder of the central 
nervous system which is the third most common disease after stroke 
and Alzheimer’s [1]. It is a group of related disorders where a person 
suffers from recurrent seizures, an abnormal, disorderly discharging of 
the brain’s nerve cells, resulting in a temporary disturbance of motor, 
sensory, or mental function. It is an urgent need to search the medicinal 
plants that can accelerate beneficial effects in seizures.
Rauvolfia belongs to the family Apocynaceae and are well known for 
the presence of indole alkaloids [2]. Rauvolfia tetraphylla L. is native to 
Mexico, Central America, West Indies, and Northern South America. It has 
been cultivated widely as both an ornamental and traditional medicine. It 
is now utilized throughout to tropics including Australia, Indonesia, China 
and India. Rouwolfia popularly used in Ayurvedic and Unani System of 
Medicines along with a part of folk remedies of most of the Asian countries 
[3]. It is commonly known as “Be still tree” or “Devil-pepper” and in Hindi 
as Barachandrika. The alkaloids isolated from the plant material show 
various pharmacological activities such as antipsychotic, antimicrobial, 
anti-inflammatory, anticancer, antihypertensive, antidiarrheal, and 
antioxidant [4]. It has been cultivated both as ornamental and traditional 
medicine and are available as endangered medicinal plant of Odisha 
(India) as shrub for the treatment of epilepsy, insomnia, wound, fever, 
colic, and urinary retention in Ayurveda. The present manuscript 
describes the anticonvulsant efficacy of the ethanolic extract of R. 
tetraphylla leaf on Swiss albino mice.
METHODS
The leaves of R. tetraphylla were collected from the herbal garden 
of the National Botanical Research Institute, Lucknow, India, 
and authenticated by Head, Department of Pharmacognosy and 
Ethnopharmacology at National Botanical Research Institute, Lucknow, 
India. A voucher specimen no NBRI/RES/RT-20 is preserved for future 
reference. The leaves were dried in shade and crushed to obtain coarse 
powder after authentication. The solvents and chemical were analytical 
grade and distilled before use.
Reagents, standards, and drugs
The drug phenytoin sodium was used as standard anticonvulsant 
drug and obtained from Zydus Cadila Healthcare Limited, India. 
The pentylenetetrazole (PTZ) (R. tetraphylla) was used as standard 
convulsion producing agent purchased from Ranbaxy, India, and the 
other chemicals such as hexane, ethanol, and dimethylsulfoxide were 
also of analytical grade.
Preparation of extract
The leaves of R. tetraphylla were powdered and sieved, followed 
by successive extraction of powdered leaves prepared on the basis 
of polarity with hexane and 250 ml of 90% ethanol using Soxhlet 
apparatus at 50°C for 80 h. The process was repeated until complete 
extraction and the pooled extract were concentrated under vacuum. 
The resultant extract was filtered (Whatman filter paper No. 1) and was 
dried/concentrated under reduced pressure using rotator evaporator. 
The extractive value obtained was approximately 30.12% w/w. The 
extract was stored in cold condition refrigerator throughout the 
duration of experimentation process.
High-performance thin-layer chromatography (HPTLC)
Preparation of working solutions of standard and sample
The working solution of standards (1 mg/ml) and samples (10 mg/ml) 
was freshly prepared in methanol. The stock solution of standards 
1 mg/mL was diluted in the same solvent to obtain a four working 
solutions in a concentration ranging from 0.1 to 0.4 mg/ml, for 
calibration.
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HPTLC procedure
It is well known that HPTLC is used for quantitative analysis, for 
sampling about 10 microliter of sample was applied using Hamilton 
syringe (Camag 100 ml syringe, Switzerland) on a pre-coated plates of 
silica gel, having thickness of 6mm. The sample was spotted 10 mm from 
the bottom and 15 mm from side of the plate by using Camaglinomat-V 
automated applicator. The applicator is facilitated by nitrogen flow 
providing a delivery speed of 150 ml/s.
Development of plates
The layers were developed in a Camag Twin Trough Glass Chamber, 
which was presaturated with mobile phase toluene: ethyl acetate: formic 
acid (7:2.5:0.5 v/v). The plate after development was dried and 
spraying agent anisaldehyde sulfuric acid was applied for derivatization 
followed by scanning at 254 nm and 366 nm. The percentage of rutin 
and gallic acid was calculated using the following formula [5]:
Sample area × standard dilution× purity × 100
Standard area × sa
( )
mple dilution× 100( )
Experimental animals
The Swiss albino mice of either sex of body weight (20–30 g) were obtained 
from Central Animal House, Rameshwaram Institute of Pharmacy (Reg. 
No - 1397/ac/10 Committee for the purpose of Control and Supervision 
of Experimental Animal [CPCSEA]). Swiss albino mice were randomly 
distributed in various groups for the treatment of standard and sample 
drugs. They were kept at one ambient temperature of 25±1°C and 45–
55% RH in polypropylene cage and acclimatized to laboratory condition 
before a week to start the experiment. The experimental protocols were 
approved by the Institutional Animal Ethics Committee constitute under 
Committee for the Purpose of CPCSEA, Government of India.
Acute oral toxicity studies
The acute toxicity study of an ethanolic extract of R. tetraphylla 
was done as per the OECD guideline No.420 (OECD, 2002). Swiss 
albino mice in three different groups of either sex were weighed and 
placed under standard condition. Method of CPCSEA was adopted 
for toxicity studies. The extracts were administered in a dose of 50, 
300, 1000, and 2000 mg/kg p.o. to different groups of mice each 
containing 10 animals, and mortality was observed after 25 h. The 
mortality dose of animals is 2000 mg/Kg.
Drug treatment
Swiss albino mice were treated both with standardized ethanolic 
leaf extract of R. tetraphylla in a dose of 200, 400, or 600 mg/kg and 
the standard drug phenytoin sodium in a dose of 25 mg/kg for 7 
consecutive days. Saline solution is used as control using electrical 
(maximal electroshock seizure [MES]) and chemical (PTZ) method.
Screening of anticonvulsant activity
The Swiss albino mice were divided into five groups, and screening of 
anticonvulsant activity was done by MES model and PTZ model.
Effect of extract on MES-induced seizures
This is the best model for generalized seizures of tonic-clonic type [6,7]. 
In this model, rats receive an electrical shock of 50 mA and 50 Hz for 
a duration of 2 s to induce seizures by electroconvulsiometer. Swiss 
albino mice were divided into a five groups (n=6): Group I, Group II, 
Group III, Group IV, and Group V.
Group I was served as control and received only saline water; Groups II, 
III, and VI get the ethanolic extract of R. tetraphylla in oral doses of 200, 
400, or 600 mg/kg and the Group V gets the standard drug phenytoin 
sodium in a dose of 25 mg/kg. The test extract was prepared in 2% v/v 
Tween 80 solution and get administered orally 1hour before inducing 
convulsions and standard drug (phenytoin sodium 25mg/Kg) was 
administered 30 min before through i.p route.
Convulsions were developed by MES; different phases of the 
convulsions (flexor, extensor, convulsion, stupor, and recovery or death) 
were observed. Hind-limb tonic extension (HLTE) phase was measured 
as the protection of the convulsion developed by MES model.
Effect of extract on PTZ-induced seizures
The standard drug PTZ which is used for the generation of seizures 
was administered in a dose of 60 mg/kg i.p 60 min before the test drug, 
i.e., the ethanolic extract of R. tetraphylla and the parameters such as 
myoclonic, clonic, and tonic–clonic seizures [8] and % protection was 
observed. In this model also, Swiss albino mice were divided into five 
groups (n=6): Group I, Group II, Group III, Group IV, and Group V; 
Group I is served as control, Groups II, III, and IV get the ethanolic 
extract in a dose of 200, 400, or 600 mg/kg, and the Group V served as 
standard received phenytoin sodium 25 mg/kg.
Statistical analysis
The data obtained by different experimental parameters were 
statistically evaluated by SPSS software and ANOVA test followed by 
student’s t-test (p<0.05) which was used to find the significance. All 
observations were expressed as mean±standard deviation, and the 
graph of each data is plotted by GraphPad Prism software.
RESULTS
HPTLC
Quantification of rutin and gallic acid was done by HPTLC; mobile 
phase used was toluene: ethyl acetate: formic acid (7:2.5:0.5 v/v) which 
shows very good resolution of spot of the sample against the standards 
on the HPTLC plate. HPTLC plates are visualized in ultraviolet light 
of 254 nm and 366 nm wavelength. Identification of the presence of 
rutin and gallic acid in the extract was performed by comparison of 
chromatogram of standard and sample, which is shown to be similar in 
Fig. 1. By these studies of HPTLC, the amount of rutin and gallic acid is 
15.60% and 7.81%, respectively (Figs. 2 and 3).
MES test
Fig. 1 Picture of leaves of Rauvolfia tetraphylla
Fig. 2: High-performance thin-layer chromatography plate with 
spots of rutin (spot 1), gallic acid (spot 2), and ethanolic extract 
(spot 3)
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MES-induced tonic seizures can be prevented either by drugs that 
inhibit voltage-dependent Na+ channels such as phenytoin, valproate, 
felbamate, and lamotrigine or by drugs that block glutaminergic 
excitation mediated by n-methyl-D-aspartate receptor, such as 
felbamate. R. tetraphylla alcoholic extract may follow any one 
of the above mechanisms. The result of anticonvulsant effect of 
R. tetraphylla leaves against MES- and PTZ-induced convulsions is 
shown in Tables 1 and 2, respectively. The one-way ANOVA analysis of 
the data observed indicated that alcoholic extract exhibited significant 
antiseizure effect against MES- and PTZ-induced seizures. Control 
group animals exhibited HLTE of 11.42±0.020 s after the delivery of 
an electroshock. Ethanolic extract at a dose of 200 mg/kg body weight 
shown very less effect on total duration of HLTE, while at the dose of 
400 and 600 mg/kg, it reduced the duration of HLTE to 4.38±0.023 
and 2.65±0.308 s, respectively. Statistically significant results were 
observed with alcoholic extract at the dose of 400 and 600 mg/kg with 
p<0.01.
PTZ-induced seizures
In PTZ-induced seizures, alcoholic extracts at a dose of 400 and 
600 mg/kg b.w. exhibited delayed onset of clonus 79.05±0.115 
and 80.57±0.425 s, respectively, in comparison to control 
77.12±0.540 s. For the extensor phase, alcoholic extract at a dose of 
400 and 600 mg/kg exhibited 298.51±0.815 and 317.22±0.030 s, 
respectively, as significant anticonvulsant activity in comparison to 
control extensor (278.11±0.220 s).
Furthermore, the study is, however, necessary to elucidate the exact 
mechanism of action and the active principle responsible for above 
activity.
DISCUSSION
The study was designed to elucidate the antioxidant constituents present 
in the plant through HPTLC as well as to screen the anticonvulsant 
activity in ethanolic leaf extract of R. tetraphylla. HPTLC results show 
that the presence of rutin and gallic acid in the extract was 15.60% and 
7.81%, respectively. The antioxidant constituents were determined 
through HPTLC because it also helps to improve the anticonvulsant 
symptoms in the patients. Anticonvulsant screening was done using 
two models, that is, MES- and PTZ-induced model. In MES model, the 
extension (HLTE) phase in three groups RT-200, RT-400, and RT-600 was 
found to be 11.48±0.086, 4.38±0.023, and 2.65±0.0308 s, respectively, 
which shows that there was a reduction in its duration. There was 
complete abolition of the extensor phase in the standard group of 
phenytoin. From the above findings, it can be observed that the ethanolic 
leaf extract of R. tetraphylla reduced the extensor phase of convulsion 
in the dose-dependent manner [9,10] with maximum effect seen at the 
dose of 600 mg/kg. In PTZ model, the onset of extensor phase increases 
with an increase in dose from 200 to 600 mg/Kg body weight.
CONCLUSION
It was found that ethanolic extract of R. tetraphylla leaves (dose 400 
and 600 mg/kg body weight) had significant activity against MES and 
PTZ convulsions when compared to control groups. The plant would be 
Fig. 3: Three-dimensional diagram of high-performance thin-layer chromatography densitograms for rutin and gallic acid, respectively
Table 1: Effect of alcoholic extract against MES-induced convulsion group time (s) in various phases of convulsions
Group Time (s) in various phases of convulsions (mean±SEM)
Flexion Extension (HLTE) Clonus Stupor Recovery
Control 3.81±0.014 11.42±0.020 14.07±0.577 92.28±0.106 120.8±1.40
Standard 1.323±0.218** 0.00 s** 7.77±0.169** 50.69±0.134** 30.32±0.811
RT-200 3.77±0.026 11.48±0.086 13.83±0.205 90.87±0.855 118.23±0.700
RT-400 2.67±0.020** 4.38±0.023** 13.49±0.410 89.84±0.622* 98.53±0.232
RT-600 62±0.030** 2.65±0.308** 9.29±0.014** 58.05±0.226** 96.78±0.410
HLTE: Hind-limb tonic extension, SEM: Standard error of the mean, MES: Maximal electroshock seizure
Table 2: Effect of alcoholic and aqueous extract on PTZ-induced convulsions
Drug Onset time in seconds (mean±SEM)
Dose (mg/Kg b.w.) Jerks Clonus Extensor
Vehicle 48.72±0.085 77.12±0.540 278.11±0.220
Standard (phenytoin Na) 25 0.00±0.000** 0.00±0.000** 0.00±0.000**
Rauvolfia tetraphylla 200 47.89±0.227 77.97±0.490 280.28±1.045
Rauvolfia tetraphylla 400 49.62±0.248 79.05±0.115* 298.51±0.815**
Rauvolfia tetraphylla 600 49.78±0332* 80.57±0.425** 317.22±0.030**
Values are mean±SEM, n=6. **p<0.01, *p<0.05 significant when compared to control. SEM: Standard error of the mean, PTZ: Pentylenetetrazole
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of great value to confirm these findings for different other doses and to 
find the exact mechanism of action with further studies on experimental 
animals and finally doing clinical studies to make it available for use in 
human beings in a commercial way.
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